普益药茶治疗非酒精性脂肪肝的临床观察

Clinical Observation on Puyi Herbal Tea in the Treatment of Non-alcoholic Fatty Liver

目的观察与分析普益药茶防治非酒精性脂肪肝的临床疗效。方法选取在我院就诊的非酒精性脂肪肝患者64例,随机分为治疗组和对照组,治疗组给予口服普益药茶开水冲服,2次/d,对照组给予脂必泰胶囊口服,1粒/次,2次/d。观察周期为60 d。治疗前后分别观察记录患者的临床症状、腹部超声检查结果、肝功能及血脂情况。结果治疗后,2组临床症状积分明显下降,治疗组有效率93.55%,优于对照组73.33%,差异有统计学意义(P<0.05)。腹部超声情况改善,组间比较差异有统计学意义(P<0.05)。肝功能及血脂指标较治疗前显著降低(P<0.05)。2组综合临床疗效比较,治疗组优于对照组,差异有统计学意义(P<0.05)。2组患者不良反应发生率差异无统计学意义(P>0.05)。结论普益药茶能明显改善非酒精性脂肪肝脂肪肝患者的临床症状,促进肝脏功能恢复,对非酒精性脂肪肝的治疗有显著疗效,安全性高。

Objective To observe and analyze the clinical curative effect of Puyi herbal tea in preventing non-alcoholic fatty liver. Methods64 patients with non-alcoholic fatty liver were randomly divided into treatment group and control group. The treatment group was given oral Puyi tea and soaked in boiling water for 2 times per day. The control group was given Lipbitai capsule orally,1 capsule/time,2 times per day. The observation period is 60 days. The clinical symptoms,abdominal ultrasound findings,liver function,and lipid status were recorded before and after treatment. Results After treatment,the scores of clinical symptoms in the two groups decreased significantly. The effective rate of the treatment group was 93. 55%,which was better than that of the control group（ 73. 33%）. The difference was statistically significant（ P 〈 0. 05）. Abdominal ultrasound improved,the difference between the groups was statistically significant（ P 〈 0. 05）. Liver function and blood lipids were significantly lower than before treatment（ P 〈 0. 05）. Comparing the clinical efficacy of the two groups,the treatment group was superior to the control group,and the difference was statistically significant（ P 〈 0. 05）. There was no significant difference in the incidence of adverse reactions between the two groups（ P 〉 0. 05）. Conclusion Puyi Herbal Tea can significantly improve the clinical symptoms of patients with non-alcoholic fatty liver and fatty liver,promote the recovery of liver function,has significant curative effect on the treatment of non-alcoholic fatty liver and high safety.